Plasma concentration of asymmetrical dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy

被引:0
|
作者
Lajer, M.
Tarnow, L.
Jorsal, A.
Teerlink, T.
Parving, H.-H.
Rossing, P.
机构
[1] Steno Diabet Ctr, DK-2820 Gentofte, Denmark
[2] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[3] Univ Copenhagen Hosp, Rigshosp, Dept Med Endocrinol, DK-2100 Copenhagen, Denmark
[4] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1138
引用
收藏
页码:S468 / S468
页数:1
相关论文
共 50 条
  • [31] Intensity of exercise predicts cardiovascular complications in type 1 diabetic patients
    Tikkanen, H.
    Waden, J.
    Forsblom, C.
    Thorn, L. M.
    Saraheimo, M.
    Tolonen, N.
    Rosengard-Barlund, M.
    Gordin, D.
    Tikkanen, H.
    Groop, P. -H.
    EUROPEAN HEART JOURNAL, 2014, 35 : 700 - 700
  • [32] Progression of diabetic nephropathy in normotensive type 1 diabetic patients
    Jacobsen, P
    Rossing, K
    Tarnow, L
    Rossing, P
    Mallet, C
    Poirier, O
    Cambien, F
    Parving, HH
    KIDNEY INTERNATIONAL, 1999, 56 : S101 - S105
  • [33] Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy
    Jorsal, A.
    Tarnow, L.
    Flyvbjerg, A.
    Parving, H. -H.
    Rossing, P.
    Rasmussen, L. M.
    DIABETOLOGIA, 2008, 51 (11) : 2100 - 2107
  • [34] Variability of Glycated Albumin Predicts the Progression of Diabetic Nephropathy in Type 2 Diabetic Patients
    Kim, Eun Heui
    Park, Su Bin
    Nam, Yoon Jeong
    Ahn, Kang Hee
    Moon, Seong Su
    Chun, Sung Wan
    Lee, Min Jin
    Kwon, Sang Chang
    Seo, Ji Young
    Jeon, Yun Kyung
    Kim, Bo Hyun
    Kim, In Joo
    Kim, Sang Soo
    DIABETES, 2015, 64 : A153 - A153
  • [35] ACE inhibition decreases asymmetrical dimethylarginine levels and improves endothelial function in type 1 diabetic patients
    Yazici, D
    Yavuz, D
    Unsalan, S
    Toprak, A
    Deyneli, O
    Yuksel, M
    Aydin, H
    Tezcan, H
    Akalin, S
    DIABETES, 2005, 54 : A188 - A188
  • [36] Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy
    A. Jorsal
    L. Tarnow
    A. Flyvbjerg
    H.-H. Parving
    P. Rossing
    L. M. Rasmussen
    Diabetologia, 2008, 51 : 2100 - 2107
  • [37] Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathy
    Overgaard, Anne Julie
    Hansen, Henning Gram
    Lajer, Maria
    Pedersen, Lykke
    Tarnow, Lise
    Rossing, Peter
    McGuire, James N.
    Pociot, Flemming
    PROTEOME SCIENCE, 2010, 8
  • [38] Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathy
    Overgaard, A. J.
    Lajer, M.
    Tarnow, L.
    Rossing, P.
    McGuire, J. N.
    Pociot, F.
    DIABETOLOGIA, 2009, 52 : S425 - S425
  • [39] Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathy
    Anne Julie Overgaard
    Henning Gram Hansen
    Maria Lajer
    Lykke Pedersen
    Lise Tarnow
    Peter Rossing
    James N McGuire
    Flemming Pociot
    Proteome Science, 8
  • [40] Plasma Growth Differentiation Factor-15 Independently Predicts All-Cause and Cardiovascular Mortality As Well As Deterioration of Kidney Function in Type 1 Diabetic Patients With Nephropathy
    Lajer, Maria
    Jorsal, Anders
    Tarnow, Lise
    Parving, Hans Henrik
    Rossing, Peter
    DIABETES CARE, 2010, 33 (07) : 1567 - 1572